piribedil has been researched along with Drooling in 1 studies
Piribedil: A dopamine D2 agonist. It is used in the treatment of parkinson disease, particularly for alleviation of tremor. It has also been used for circulatory disorders and in other applications as a D2 agonist.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The inclusion of piribedil (150-250 mg/day) in the 6-months therapy reduces the dysfunction of the upper gastrointestinal tract (by 61 and 74% of the initial level of dysphagia and sialorrhea, respectively) regardless the drug use in monotherapy or in complex therapy with levodopa." | 4.12 | [Upper gastrointestinal tract dysfunction and its correction by dopamine agonists for patients with Parkinson's disease of I-III stage]. ( Pilipovich, AA; Vorob'eva, OV, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pilipovich, AA | 3 |
| Vorob'eva, OV | 3 |
1 other study available for piribedil and Drooling
| Article | Year |
|---|---|
[Upper gastrointestinal tract dysfunction and its correction by dopamine agonists for patients with Parkinson's disease of I-III stage].
Topics: Adult; Aged; Aged, 80 and over; Deglutition Disorders; Dopamine Agonists; Female; Gastrointestinal D | 2022 |
[Upper gastrointestinal tract dysfunction and its correction by dopamine agonists for patients with Parkinson's disease of I-III stage].
Topics: Adult; Aged; Aged, 80 and over; Deglutition Disorders; Dopamine Agonists; Female; Gastrointestinal D | 2022 |
[Upper gastrointestinal tract dysfunction and its correction by dopamine agonists for patients with Parkinson's disease of I-III stage].
Topics: Adult; Aged; Aged, 80 and over; Deglutition Disorders; Dopamine Agonists; Female; Gastrointestinal D | 2022 |
[Upper gastrointestinal tract dysfunction and its correction by dopamine agonists for patients with Parkinson's disease of I-III stage].
Topics: Adult; Aged; Aged, 80 and over; Deglutition Disorders; Dopamine Agonists; Female; Gastrointestinal D | 2022 |